Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2.
about
An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.Epigenetic Component p66a Modulates Myeloid-Derived Suppressor Cells by Modifying STAT3.Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates.TGF-β3-induced miR-494 inhibits macrophage polarization via suppressing PGE2 secretion in mesenchymal stem cells.
P2860
Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Doxorubicin resistant cancer c ...... essor cells by releasing PGE2.
@en
type
label
Doxorubicin resistant cancer c ...... essor cells by releasing PGE2.
@en
prefLabel
Doxorubicin resistant cancer c ...... essor cells by releasing PGE2.
@en
P2093
P2860
P356
P1433
P1476
Doxorubicin resistant cancer c ...... essor cells by releasing PGE2.
@en
P2093
Chun-Hui Yuan
Fu-Bing Wang
Xiao-Hua Leng
P2860
P2888
P356
10.1038/SREP23824
P407
P577
2016-04-01T00:00:00Z
P5875
P6179
1018482890